Rising Healthcare Costs Push Employers Toward Greater Benefits Oversight

Rhea-AI Summary

Gallagher (NYSE: AJG) released its 2026 US Benefits Benchmarks findings, based on responses from more than 3,700 employers, showing organizations tightening governance, analytics and vendor oversight to confront rising healthcare costs and regulatory complexity.

According to Gallagher, 36% of employers saw health plan premium hikes of at least 10% at their latest renewal, pressuring traditional cost-containment tactics. Employers are intensifying scrutiny of pharmacy benefits, with 49% citing specialty drug costs, including GLP‑1 therapies, as a top challenge and seeking more transparent PBM relationships and targeted utilization management.

The report notes growing use of voluntary benefits to fill coverage gaps and enhance financial protection, alongside increased adoption of digital decision-support tools. Gallagher also highlights that 23% of employers report wellbeing participation below 20%, and 37% now use analytics to guide workforce planning and benefit decisions.

Market Context

AJG's recent insider record was Net Selling, with one reported sale. Against this benefits-cost repo...

Analysis

AJG's recent insider record was Net Selling, with one reported sale. Against this benefits-cost report, that context adds a cautious ownership signal; low short positioning offers limited evidence of crowded bearish positioning. Watch employer demand and execution.

Key Figures

Organizations surveyed: more than 3,700 organizations Premium increases: 36% reporting increases of 10% or more Specialty drug cost challenge: 49% +4 more

7 metrics

Organizations surveyed more than 3,700 organizations 2026 Workforce Trends Report – Benefits Benchmarks

Premium increases 36% reporting increases of 10% or more most recent health plan renewal

Specialty drug cost challenge 49% employers identifying rising specialty drug costs as a top challenge

Comprehensive benefits package 72% reason employers provide voluntary benefits

Coverage gaps 66% reason employers provide voluntary benefits

Low wellbeing participation 23% reporting fewer than 20% participation eligible employees in wellbeing initiatives

Analytics adoption 37% employers leveraging analytics for workforce planning and decision-making

Historical Context

5 past events · Latest: Aug 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 05	Apollo acquisition	Positive	+1.2%	Acquisition expanded Gallagher's Canadian digital insurance brokerage capabilities.
Jul 30	2Q26 earnings report	Neutral	-2.8%	Adjusted growth contrasted with lower reported earnings and diluted EPS.
Jul 29	Quarterly dividend	Positive	-4.6%	Company declared a regular third-quarter cash dividend of $0.70 per share.
Jul 29	Director succession	Negative	+1.4%	Director David Johnson's passing led to board-size reduction and leadership reassignment.
Jul 21	Tuscano acquisition	Positive	-2.1%	RPS acquired a Pennsylvania managing general agency and wholesale broker.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent AJG announcements frequently diverged from favorable or routine event framing, with four of five events followed by negative or contrary price reactions.

Key Terms

pharmacy benefit manager, glp-1 medications, utilization management

3 terms

pharmacy benefit manager financial

"greater transparency in pharmacy benefit manager (PBM) relationships"

A pharmacy benefit manager (PBM) is a company that manages prescription drug plans for health insurance providers, employers, and other organizations. They negotiate prices with drugmakers, decide which medicines are covered, and handle the distribution of prescriptions. For investors, PBMs are important because they influence healthcare costs and profit margins in the pharmacy industry.

glp-1 medications medical

"including GLP-1 medications"

GLP-1 medications are drugs that copy a natural gut hormone to help the body release insulin, lower blood sugar and reduce appetite by slowing how quickly the stomach empties. For investors, they matter because their strong clinical benefits have driven rapid sales growth, reshaped demand for diabetes and weight-loss treatments, and created regulatory, patent and pricing dynamics that can significantly affect healthcare companies’ revenues and profitability.

utilization management medical

"and targeted utilization management"

Utilization management is the process health insurers and providers use to review and approve medical services, tests, and treatments to make sure they are necessary, appropriate, and cost-effective. For investors, it matters because these reviews influence how often care is paid for, affect healthcare providers’ revenues and drug or device sales, and can change costs and demand—like a gatekeeper deciding which requests move forward and which do not.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Gallagher's 2026 US Benefits Benchmarks report highlights how employers are using stronger governance, analytics and vendor oversight to manage rising healthcare costs

ROLLING MEADOWS, Ill., Aug. 12, 2026 /PRNewswire/ -- According to Gallagher's 2026 Workforce Trends Report – Benefits Benchmarks, US employers are taking a more disciplined approach to benefits management as rising healthcare costs, mounting regulatory complexity and pressure to maximize benefit investments intensify.  Based on responses from more than 3,700 US organizations, the report finds that employers are placing greater emphasis on governance, vendor accountability and data-informed decision making as they work to balance affordability, employee needs and long-term sustainability.

Medical cost pressure remains a dominant challenge. More than one-third of employers (36%) report health plan premium increases of 10% or more at their most recent renewal, even after implementing plan changes. Premium growth, combined with claims volatility and rising medical service costs, particularly hospital pricing and variation in site of care, is putting pressure on traditional cost-containment strategies. In response, organizations are taking a more proactive approach to managing plans, evaluating funding strategies, monitoring vendor performance and identifying opportunities to improve outcomes.

"At a time when cost pressure is persistent and difficult to forecast, employers can't rely on periodic plan changes alone," said John Tournet, US CEO of Gallagher's Benefits & HR Consulting Division. "They're adopting a more disciplined approach built on stronger data, closer oversight and ongoing evaluation of plan performance. We're also seeing growing interest in tools and technologies, including AI-enabled capabilities, that can help employers uncover trends, identify emerging risks and make more informed decisions."

Pharmacy benefits have become one of the most closely scrutinized areas of healthcare spending. Nearly one in two employers (49%) identify the rising cost of specialty drugs as a top healthcare cost challenge, reflecting the growing impact of high-cost therapies, including GLP-1 medications. Rather than shifting more costs to employees, organizations are focusing on greater transparency in pharmacy benefit manager (PBM) relationships, more disciplined pricing review and targeted utilization management.

As organizations look for ways to extend workforce support without significantly increasing costs, voluntary benefits are taking on a larger role within total rewards strategies. Employers most often cite offering a more comprehensive benefits package (72%), addressing coverage gaps (66%) and enhancing financial protection for employees (49%) among the reasons for providing voluntary benefits. Interest is also growing in supplemental offerings such as employee perks or discount programs (51%, up 7 points from 2023), identity theft protection (42%, up 8 points) and pet insurance (36%, up 13 points), highlighting a broader focus on financial and lifestyle support. As benefit portfolios become more diverse, employers are increasingly leveraging digital decision-support tools to help employees better understand and navigate their options.

With employer investments in wellbeing continuing to evolve, participation remains a key measure of program effectiveness. Nearly one in four employers (23%) report that fewer than 20% of eligible employees participate in wellbeing initiatives. This gap is prompting a shift away from stand-alone programs toward more integrated approaches that connect health, financial wellbeing and the day-to-day employee experience. Employers are focusing on making benefits easier to access, understand and use throughout the year rather than only during enrollment periods.

"Technology is changing how employees interact with benefits just as much as it's changing how employers manage them," Tournet added. "Whether it's better communication, simpler navigation or digital tools that help support more relevant guidance, the goal is the same: helping employees make confident decisions while improving the overall benefits experience."

Across these areas, a common theme is emerging: benefits strategy is becoming less about adding new programs and more about executing existing ones with greater precision. Reflecting this shift, more than a third of employers (37%) report leveraging analytics to inform workforce planning and decision-making, underscoring the importance of data in benefits management.

In an environment of rising costs and growing complexity, employers are placing greater emphasis on how they manage, measure and optimize their benefit investments. Data-driven decision-making is playing a growing role in helping organizations evaluate outcomes and deliver meaningful value for both employers and their employees.

ABOUT THE REPORT
Gallagher's 2026 US Workforce Trends Report – Benefits Benchmarks reflects survey responses from 3,717 US organizations collected from January through March 2026 and provides benchmarking data and insights across medical, pharmacy and voluntary benefits, wellbeing initiatives and absence management.

ABOUT GALLAGHER
Arthur J. Gallagher & Co. (NYSE:AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. Gallagher provides these services in approximately 130 countries around the world through its owned operations and a network of correspondent brokers and consultants.

CONTACT:  
Mary Schwartz, Gallagher
847.378.5893
mary_schwartz@ajg.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rising-healthcare-costs-push-employers-toward-greater-benefits-oversight-302849374.html

SOURCE Gallagher

FAQ

What does Gallagher's 2026 US Benefits Benchmarks report reveal about rising healthcare costs for employers (NYSE: AJG)?

Gallagher’s 2026 report shows many employers face significant healthcare cost pressure, especially premium hikes and specialty drug expenses. According to Gallagher, 36% experienced health plan premium increases of 10% or more at renewal, pushing employers toward stronger governance, analytics and vendor oversight to manage benefits more effectively.

How are US employers responding to higher medical premiums according to Gallagher's 2026 Benefits Benchmarks (AJG)?

Employers are responding by moving from periodic plan tweaks to ongoing, data-driven benefits management. According to Gallagher, organizations are evaluating funding strategies, closely monitoring vendor performance and using analytics to identify opportunities to improve outcomes while balancing affordability, employee needs and long-term plan sustainability.

What does Gallagher (AJG) say about specialty drug and GLP-1 costs in its 2026 Workforce Trends report?

Gallagher reports that specialty drug spending is a major cost driver for employer health plans. According to Gallagher, 49% of employers identify rising specialty drug costs, including GLP‑1 medications, as a top healthcare cost challenge, leading to tougher PBM scrutiny, pricing review and targeted utilization management strategies.

How are voluntary benefits being used in 2026 according to Gallagher's AJG benefits benchmarks?

Gallagher finds employers increasingly rely on voluntary benefits to enhance total rewards without sharply raising core plan costs. According to Gallagher, key goals include offering more comprehensive packages (72%), addressing coverage gaps (66%) and improving financial protection (49%), plus growing interest in perks, identity protection and pet insurance.

What participation challenges in wellbeing programs does Gallagher (NYSE: AJG) highlight for 2026?

Gallagher highlights low employee engagement as a key wellbeing challenge for employers. According to Gallagher, nearly 23% of organizations report fewer than 20% of eligible employees participate in wellbeing initiatives, prompting a shift toward integrated approaches that connect health, financial wellbeing and everyday employee experience.

How are employers using analytics in benefits decisions, according to Gallagher's 2026 AJG report?

Employers are increasingly turning to analytics to guide benefits and workforce planning decisions. According to Gallagher, 37% of employers report leveraging analytics to inform workforce planning and decision-making, supporting closer oversight of plan performance and more precise execution of existing benefit strategies rather than simply adding new programs.